Smith provided 2026 annual guidance on non-GAAP operating expenses, stating, "We anticipate approximately $385 million to $415 million, which includes non-GAAP R&D expenses of $197 million to $213 ...

PMPA members are exactly the kind of organizations that benefit from a clear operating rhythm, strong KPI visibility, and a culture of healthy accountability.” — Amy Ankrum, CEO of Rhythm Systems ...

IMCIVREE® (setmelanotide) launched in the U.S. for acquired hypothalamic obesity; more than 150 patient start forms received ...

Rhythm Systems’ advances strategy execution by bringing live execution data into the AI tools leaders use every day ...